FDA Letter API

Christoferson Meat Company Inc. dba Raws for Paws LLC

Letter data

Company
Christoferson Meat Company Inc. dba Raws for Paws LLC
Recipient
Mark G. Mann | Owner | Christoferson Meat Company Inc. dba Raws for Paws LLC | 2700 26th Avenue South | Minneapolis | , | MN | 55406 | United States
Issue date
2019-06-11
Posted date
Not available
FDA office
Division of Compliance
Subject
Not available
Product
Animal & Veterinary
CMS ID
555466
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Christoferson Meat Company Inc. dba Raws for Paws LLC MARCS-CMS 555466 — June 11, 2019 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: Overnight Delivery Product: Animal & Veterinary Recipient: Recipient Name Mark G. Mann Recipient Title Owner Christoferson Meat Company Inc. dba Raws for Paws LLC 2700 26th Avenue South Minneapolis , MN 55406 United States Issuing Office: Division of Compliance 7519 Standish Place Rockville , MD 20855 United States Dear Mr. Mann: The Food and Drug Administration has completed an evaluation of your firm’s corrective actions in response to our Warning Letter, dated October 25, 2018. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter by discontinuing the manufacturing and distribution of raw pet food. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory actions should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Eric M. Nelson Director, Division of Compliance Center for Veterinary Medicine Content current as of: 05/21/2020 Regulated Product(s) Animal & Veterinary